Seeking Alpha
View as an RSS Feed

Robert Honeywill  

View Robert Honeywill's Comments BY TICKER:
Latest  |  Highest rated
  • Johnson & Johnson: A Dividend Growth Powerhouse In The Making? [View article]
    Hi RyanV,

    Buyandhold 2012 did not say "wait for a 20% drop in the overall stock market", Rather, he said, "...buying them when they are fairly cheap".

    Over the course of a year the JNJ share price fluctuates fairly widely and there are always opportunities arising to "buy when they are fairly cheap".

    I demonstrated this in my article, "Johnson & Johnson: Growth-Growth-Growth; Win-Win-Win - Part V" http://seekingalpha.co....

    Table 3 from my above referenced article shows high and low PE ratios for 2014 of 21.1 and 16.7 and for 2013 19.8 and 15.3.

    Kind regards, Robert
    Mar 27, 2015. 06:38 PM | 1 Like Like |Link to Comment
  • Johnson & Johnson: A Dividend Growth Powerhouse In The Making? [View article]
    Hi Buyandhold 2012

    I did some detailed research on this question of timing when to buy JNJ in my article, "Johnson & Johnson: Growth-Growth-Growth; Win-Win-Win - Part V" http://seekingalpha.co....

    My research clearly showed that firstly, opportunistic buying when the price is down (based on relative PE ratios) significantly benefits overall return, and secondly, there are always opportunities arising to buy the "dips". And there have been many of these opportunities arising over the last 2 to 5 years, as well as over the last 10 years.

    Table 3 from my above referenced article shows high and low PE ratios for 2014 of 21.1 and 16.7 and for 2013 19.8 and 15.3.

    Buying at the lower PE ratio would make a very significant difference to overall returns from an investment in JNJ.

    So I strongly support your comment.

    Kind regards, Robert
    Mar 27, 2015. 06:31 PM | 1 Like Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi User 12201901

    Firstly, please see my reply above to us44ever.

    On closer analysis the temporary delay to enrollments is not so significant as at first glance.

    I do agree that the pace of enrollments is a key issue. 25 days of enrollment will be lost in Qtr 1, so if I were expecting 20 in Q1 I would now have to reduce that to 14 on a proportional basis.

    I believe it will be important for SSH to release up to date enrollment figures at the cc on 17 March. I will be looking to see how actual numbers compare to my projection of 14.

    Kind regards, Robert
    Mar 6, 2015. 08:06 PM | 1 Like Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi Bowtie

    Please see firstly my reply above to us44ever.

    I have a deal of respect for your various opinions expressed in the commentary. But I do question your comments above.

    I thought you would be aware once Rosa, or any of the Management of SSH who have automatic disposals of shares to meet tax on newly vesting shares, enters into these automatic sale arrangements he has no control over the disposal, whether or not he knows of something that could cause an increase or decrease in price. That is the whole idea, the decision to sell is taken out of his hands so it is not possible for any insider knowledge to have any influence. If you do not agree with what I am saying here please let me know your reasons.

    Without being seen as an apologist for SSH Management, I would ask how the Management of SSH could possibly be held accountable for enrollees dying from non-device related causes? Because that is what seems to be implied in that paragraph of your comment.

    As regards Dave Rosa's suitability for the job, I have to say one of the most important roles of a CEO in an early stage cash consuming company like SSH is raising capital on good terms. Some would say it is the most important role. Dave Rosa's record so far is very good in this respect, based on the price of the $40M plus raising in September 2013. The current share price, in my opinion, is a fraction of the underlying fundamental value. But what really matters is the share price at the time of the next capital raising. I expect that with C-Pulse 2 FIM progress, and accelerating enrollments once this suspension is lifted, there is room for considerable optimism about the next capital raise. This is particularly so with the extension of the capital raising window with the loan arrangement.

    I suspect perhaps your comments were in part a knee jerk reaction to the shock news of the 4 deaths. Please keep on commenting.

    Kind regards, Robert
    Mar 6, 2015. 07:52 PM | 2 Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi SivartLNG

    See my reply above to Hi us44ever.

    Kind regards, Robert
    Mar 6, 2015. 07:00 PM | Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi us44ever,

    While this is very unwelcome news, if, as indicated, all 4 deaths are confirmed as non-device related, it has no impact whatsoever on either the efficacy or safety of C-Pulse. Nothing has changed in that regard.

    The pause in enrollments including the 30 day FDA review period will be 25 days in 1st Qtr and 15 days in 2nd Qtr.

    In Tables 2 and 3 in the above article, I had allowed for 20 enrollments in 1st Qtr and 25 in 2nd Qtr. On a proportionate basis, the lost days would translate to a loss of 6 enrolled in 1st Qtr, and 4 in 2nd Qtr.

    On that basis, the revised estimates would be 14 in 1st Qtr, 21 in 2nd Qtr and progressive enrollments at end of September 2015 of 105 (still above the 100 required for the third installment of the loan).

    As the screening process for enrollment will continue during the pause,it is possible for there to be a catch up in enrollment numbers once the trial enrollment resumes.

    As enrollments are suspended, I expect 1st Qtr actual enrollment numbers will be available at the 17 March conference call. That will be a figure to look out for.

    Kind regards, Robert
    Mar 6, 2015. 06:16 PM | Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi Biotec researcher,
    For the most part, C-Pulse addresses a different market to LVADs.

    There will always be a place for LVADs, where the patient's heart has deteriorated beyond a point that C-Pulse can aid its recovery.

    This is because C-Pulse is a heart assist device while an LVAD is a full flow device that can completely take over the pumping from the left ventricle.

    In C-Pulse's less sick late stage heart failure patients the risks associated with LVADs have so far been considered too great compared to the benefits.

    Your comment , "surgeons take a long time to diverge from one technology to another" is relevant.

    The task for HTWR to introduce its HVAD was made easier because they were not introducing a divergent technology. Thoratec had already introduced the LVAD technology and established the market.

    HTWR entered the market via EU whereas SSH is obviously entering the market by the US. The EU trial is principally for facilitating release of C-Pulse performance due to inability to release US results on a progressive basis. I think you will find SSH are conserving effort and cash in EU so as to stretch funds in the US.

    Kind regards, Robert
    Mar 5, 2015. 08:13 AM | Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi stockmaster1974,
    Not sure if you are asking if there is a problem, or suggesting there is a problem, with these automatic sales of a portion of vesting shares to pay the tax on these vesting shares.

    Either way please read my response to you above.

    Kind regards, Robert
    Mar 5, 2015. 07:56 AM | Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi meshameco,
    The shorts and other market manipulators presently play with the stock price, because they can. But it does not change the fundamentals.
    Kind regards, Robert
    Mar 5, 2015. 07:51 AM | 1 Like Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi Logribel,
    Always good to hear from you.
    Kind regards, Robert
    Mar 5, 2015. 07:49 AM | Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi stockmaster1974,

    oneotherfool has answered your question below. This is a very normal process.
    If anyone tells you there is anything unusual or untoward about this then they are quite ignorant of these very usual and completely above board arrangements.

    Kind regards, Robert
    Mar 5, 2015. 07:47 AM | 2 Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi SivartLNG
    The total expenditures for the whole of the life of the company are less than the annual R&D budgets for THOR and HTWR.

    The potential is there but it has to be realized. Time to realization certainly affects investment rate of return and a low share price would increase dilution.

    One of the next articles in this sub-set will address those concerns of yours in detail.

    I have already run the numbers and SSH can potentially weather massive dilution and still produce very high rates of return over the long term. I Will explain that in detail in the article.

    On the question of a one product company, that makes it that more valuable to a potential acquirer that just wants that one product without having to acquire a whole raft of unwanted products.

    And while it might be one product, it has the potential to treat other conditions, such as angina, and to support other than the left ventricle.

    Could a pacemaker be incorporated into the fully implantable with a tiny rechargeable battery so there would be no need to perform an operation every 7 to 10 years to replace the pacemaker battery?

    And I can think of other potential uses, but that is for another day.

    Kind regards, Robert
    Mar 5, 2015. 06:41 AM | 2 Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi sivartLNG

    Everything you say is true. The poison pill means the company is not in play, so to speak.

    A number of commenters have in the past talked about a tipping point.

    Enrollments will reach a stage where the finish line will become apparent, even if in the far distance. That will be followed by wide belief in the company and the share price will rise rapidly. That will take the market cap to over $250M and a whole lot of institutional investors will flood in.

    When will this happen? I have nominated 100 enrollments as a possible "magic number" where wide belief emerges. But a quickly accelerating rate of enrollments could have a similar effect at an earlier date.

    Kind regards, Robert
    Mar 5, 2015. 06:22 AM | 5 Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi meshameco,

    Unfortunately, the investment mandates of a great many institutions will not allow them to invest in a company with a market cap of less than $250M, let alone less than $100M.

    The floodgates will open when SSH market cap reaches and exceeds $250M.

    Kind regards, Robert
    Mar 5, 2015. 06:14 AM | 2 Likes Like |Link to Comment
  • Sunshine Heart: There Is A Silver Lining To Those Clouds [View article]
    Hi Andrew, Thanks for the pertinent comments. Kind regards, Robert
    Mar 5, 2015. 06:09 AM | Likes Like |Link to Comment
COMMENTS STATS
542 Comments
512 Likes